Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | ASPH | Q12797 | 4/20 | 0.46 |
| ▸ | KDM8 | Q8N371 | 4/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | AGER | Q15109 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | KDM4A | O75164 | 1/20 | 0.40 |
| ▸ | KDM5A | P29375 | 1/20 | 0.40 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.40 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Biphenyl SCHEMBL27944055 | 0.89 | PIK3CA (0.44) | KDM4EATMASPHKDM8MAPT | |
| SCHEMBL11175187 | 0.87 | KDM4E (0.44) | KDM4EATMASPHKDM8MAPT | |
| SCHEMBL29525861 | 0.86 | KDM4E (0.53) | KDM4EATMASPHKDM8MAPT | |
| SCHEMBL27954004 | 0.84 | CYP2A6 (0.42) | KDM4EATMMAPTALDH1A1L3MBTL1 | |
| SCHEMBL3495327 | 0.81 | KDM4E (0.50) | KDM4EATMASPHKDM8MAPT | |
| SCHEMBL29008338 | 0.81 | KDM4E (0.50) | KDM4EASPHKDM8MAPTCYP3A4 | |
| SCHEMBL19138010 | 0.80 | NAPRT (0.46) | KDM4EATMFOLH1KDM4AKDM5A | |
| SCHEMBL2224497 | 0.80 | SMN1; SMN2 (0.46) | KDM4EATMMAPTCYP3A4ALDH1A1 | |
| SCHEMBL10900359 | 0.80 | FOLH1 (0.41) | KDM4EATMCYP3A4ALDH1A1L3MBTL1 | |
| SCHEMBL27689480 | 0.80 | KDM4E (0.49) | KDM4EATMASPHKDM8MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11495755-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2022-11-08 | — | — | US | disclosed |
| EP-3719099-A1 | PHOSPHORESCENT MATERIALS | Universal Display Corporation (US) | 2020-10-07 | — | — | EP | disclosed |
| US-20200176693-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2020-06-04 | — | — | US | disclosed |
| EP-3327100-B1 | PHOSPHORESCENT MATERIALS | UNIVERSAL DISPLAY CORP (US) | 2020-05-06 | — | — | EP | disclosed |
| US-10600975-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-03-24 | — | — | US | disclosed |
| US-20190157576-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2019-05-23 | — | — | US | disclosed |
| US-10230060-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-03-12 | — | — | US | disclosed |
| CN-106057162-B | Display device | 株式会社半导体能源研究所 | 2019-01-22 | — | — | CN | disclosed |
| EP-3327100-A2 | PHOSPHORESCENT MATERIALS | Universal Display Corporation (US) | 2018-05-30 | — | — | EP | disclosed |
| US-20180145267-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2018-05-24 | — | — | US | disclosed |
| US-6489315-B1 | NOVEL CYCLIC COMPOUNDS HAVING AN EXCELLENT TACHYKININ RECEPTOR ANTAGONISTIC EFFECT, AND A METHOD FOR PRODUCING THEM, FOR TREATING DISORDERS OF INCONTINENCE, ASTHMA, MIGRAINE, IRRITABLE BOWEL SYNDROME, PAIN, COUGH OR EMESIS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2002-12-03 | — | — | US | disclosed |
| US-20020132817-A1 | Heterocyclic compounds, their production and use | NATSUGARI HIDEAKI (JP) | 2002-09-19 | — | — | US | disclosed |
| EP-1184036-A2 | Heterocyclic compounds, their production and use as tachykinin receptor antagonists | Takeda Chemical Industries, Ltd. (JP) | 2002-03-06 | — | — | EP | disclosed |
| CN-1291099-A | Heterocyclic compounds, their production and use | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2001-04-11 | — | — | CN | disclosed |
| EP-1061926-A2 | HETEROCYCLIC COMPOUNDS, THEIR PRODUCTION AND USE AS TACHYKININ RECEPTOR ANTAGONISTS | Takeda Chemical Industries, Ltd. (JP) | 2000-12-27 | — | — | EP | disclosed |
| US-6147071-A | TACHYKININ RECEPTOR ANTAGONIST | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2000-11-14 | — | — | US | disclosed |
| WO-1999047132-A2 | HETEROCYCLIC COMPOUNDS, THEIR PRODUCTION AND USE AS TACHYKININ RECEPTOR ANTAGONISTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1999-09-23 | — | — | WO | disclosed |
| US-5786352-A | CARDIOVASCULAR DISORDERS, TACHYKININ RECEPTOR ANTAGONIST | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1998-07-28 | — | — | US | disclosed |
| US-5770590-A | EXCELLENT TACHYKININ RECEPTOR ANTAGONIST | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1998-06-23 | — | — | US | disclosed |
| EP-0733632-A1 | Cyclic compounds, their production and use as tachykinin receptor antagonists | Takeda Chemical Industries, Ltd. (JP) | 1996-09-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200176693-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | RUVBL2, TERT, OR10J3 | KDM4E 3403/4885ATM 2489/4885ASPH 4642/4885 |
| US-20180145267-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | PIEZO1, ORAI2, ICMT | KDM4E 3053/4885ATM 1596/4885ASPH 4413/4885 |
| US-11495755-B2 | Organic electroluminescent materials and devices | RUVBL2, TERT, OR10J3 | KDM4E 3403/4885ATM 2489/4885ASPH 4642/4885 |
| US-10230060-B2 | Organic electroluminescent materials and devices | RUVBL2, OR10J3, EML4 | KDM4E 3060/4885ATM 2401/4885ASPH 4576/4885 |
| US-10600975-B2 | Organic electroluminescent materials and devices | TERT, OR10J3, RUVBL2 | KDM4E 3344/4885ATM 2360/4885ASPH 4555/4885 |
| US-20020132817-A1 | Heterocyclic compounds, their production and use | CRH, CRHR1, CRHR2 | KDM4E 2384/4885ATM 3405/4885ASPH 1195/4885 |
| US-20190157576-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | PIEZO1, ORAI2, PORCN | KDM4E 3726/4885ATM 1404/4885ASPH 4343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.